Go here to read the rest: SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
Go here to read the rest: SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
Original post: Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
Follow this link: Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Read more here: Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April...
See the original post: SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
Go here to read the rest: Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Here is the original post: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Read more: Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
Read more here: Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Recent Comments